Kliniske forsøg med Neurofibromatosis tipo 2
I alt 11378 resultater
-
NYU Langone HealthNovartis Pharmaceuticals; The Children's Tumor FoundationAfsluttetNeurofibromatose type IIForenede Stater
-
University of Alabama at BirminghamAfsluttetNeurofibromatosis type 1 og voksende eller symptomatisk, inoperabel PNForenede Stater
-
Massachusetts Eye and Ear InfirmaryRekruttering
-
National Institute of Neurological Disorders and...RekrutteringNeurofibromatoseForenede Stater
-
NYU Langone HealthAfsluttet
-
Manchester University NHS Foundation TrustAfsluttetNeurofibromatose type 2Det Forenede Kongerige
-
PTC TherapeuticsUnited States Department of DefenseAfsluttet
-
AstraZenecaAfsluttetSunde deltagere | Neurofibromatosis Type 1 (NF1)-relaterede plexiforme neurofibromer (PN'er)Forenede Stater
-
NYU Langone HealthGlaxoSmithKlineAfsluttetNeurofibromatose 2 | Vestibulær SchwannomaForenede Stater
-
Recursion Pharmaceuticals Inc.RekrutteringNeurofibromatose type 2Forenede Stater
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsAfsluttetNeurom, akustisk | Neurofibromatose type 2Forenede Stater
-
NYU Langone HealthAfsluttetNeurofibromatose type 2 | Vestibulære SchwannomasForenede Stater
-
Li PengBetta Pharmaceuticals Co., Ltd.AfsluttetNeurofibromatose type 2 | Vestibulær SchwannomaKina
-
National Cancer Institute (NCI)AfsluttetNeurofibromatose type 2 | Vestibulær SchwannomaForenede Stater
-
Beijing Tiantan HospitalShandong Simcere-Medgenn Bio-pharmaceutical Co., LtdAfsluttetNeurofibromatose type 2 | Vestibulær SchwannomaKina
-
SpringWorks Therapeutics, Inc.LedigNeurofibromatosis Type 1-associerede plexiforme neurofibromer | Histiocytisk neoplasma | Andre MAP-K Pathway-drevne sygdomme
-
University of Alabama at BirminghamMemorial Sloan Kettering Cancer CenterAktiv, ikke rekrutterendeNeurofibromatose 2 | Progressivt vestibulært Schwannom (VS)Forenede Stater
-
University of Alabama at BirminghamGenentech, Inc.AfsluttetNeurofibromatose type 2 | Progressive Vestibulære SchwannomasForenede Stater
-
University Hospital TuebingenNational Center for Tumor Diseases, HeidelbergAfsluttetNeurofibromatose type 2 | Vestibulær Schwannoma | Akustisk neuromTyskland
-
University of UtahUniversity of British Columbia; Children's Hospital Medical Center, Cincinnati og andre samarbejdspartnereAfsluttetNeurofibromatose type 1 (NF1)Forenede Stater, Canada
-
Massachusetts Eye and Ear InfirmaryIkke længere tilgængeligNeurofibromatose type 2 | Svært dybt sensorineuralt høretabForenede Stater
-
Johns Hopkins UniversityNeurofibromatosis Therapeutic Acceleration ProgramRekrutteringNeurofibromatose 1 | Neurofibromatose type 1 | Kutan neurofibrom | Neurofibromatose (ikke-malign)Forenede Stater
-
National Cancer Institute (NCI)AfsluttetPlexiformt neurofibrom | Neurofibromatose type IForenede Stater
-
Massachusetts General HospitalThe Children's Tumor FoundationAfsluttetNeurofibromatose | Neurofibromatose 2 | Schwannomatose | Neurofibromatose IForenede Stater
-
Novartis PharmaceuticalsAfsluttetPlexiformt neurofibrom forbundet med neurofibromatose type 1Israel
-
AstraZenecaRekrutteringNeurofibromatose type 1Portugal, Spanien, Det Forenede Kongerige, Israel, Frankrig, Italien, Schweiz, Tyskland, Østrig
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Ikke rekrutterer endnu
-
Assistance Publique - Hôpitaux de ParisAfsluttetNeurofibromatose type 1Frankrig
-
Children's National Research InstituteEmory University; University of Texas Southwestern Medical Center; Arizona...Afsluttet
-
Shriners Hospitals for ChildrenUniversity of Utah; Thrasher Research FundAfsluttetNeurofibromatose type 1Forenede Stater
-
University Hospital, ToulouseUkendtNeurofibromatose type 1Frankrig
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Children's Hospital of Philadelphia; Washington... og andre samarbejdspartnereAfsluttetNeurofibromatose type 1Forenede Stater, Australien
-
Tel-Aviv Sourasky Medical CenterUkendtNeurofibromatose type 1
-
Scott R. Plotkin, MD, PhDTakeda; National Comprehensive Cancer Network; The Children's Tumor FoundationRekrutteringEpendymom | Meningiom | Neurofibromatose type 2 | Vestibulær Schwannoma | Ikke-vestibulært SchwannomForenede Stater
-
Ann & Robert H Lurie Children's Hospital of ChicagoNational Institute of Neurological Disorders and Stroke (NINDS); Children...RekrutteringNeurofibromatose 1 | Neurofibromatose type 1 | NF1Forenede Stater
-
Guy's and St Thomas' NHS Foundation TrustRekrutteringNeurofibromatose type 1Det Forenede Kongerige
-
University Hospital, Strasbourg, FranceRekrutteringNeurofibromatose type 1Frankrig
-
Donald BaselRekruttering
-
National Cancer Institute (NCI)AfsluttetNeurofibrom | Neurofibromatose type 1Forenede Stater
-
SpringWorks Therapeutics, Inc.Aktiv, ikke rekrutterendePlexiformt neurofibrom | Neurofibromatose type 1 (NF1)Forenede Stater
-
National Cancer Institute (NCI)AfsluttetNeurofibromatose type 1 | Legius syndromForenede Stater
-
Massachusetts Eye and Ear InfirmaryJohns Hopkins University; Mayo Clinic; Stanford University; Ohio State University og andre samarbejdspartnereAfsluttetMeningiom | Neurofibromatose type 2 | Vestibulær Schwannoma | Akustisk neuromForenede Stater
-
AstraZenecaMerck Sharp & Dohme LLCRekrutteringNeurofibromatose type 1Forenede Stater, Spanien, Tyskland, Den Russiske Føderation, Japan, Italien, Holland
-
Shriners Hospitals for ChildrenAfsluttetNeurofibromatose type 1Forenede Stater
-
Washington University School of MedicineAfsluttet
-
Ann & Robert H Lurie Children's Hospital of ChicagoAfsluttet
-
Guy's and St Thomas' NHS Foundation TrustAfsluttetNeurofibromatose 1, NF1Det Forenede Kongerige
-
KU LeuvenUkendtNeurofibromatose type 1Belgien
-
National Institute of Neurological Disorders and...AfsluttetNeoplasmer | Vestibulær sygdom | Sygdom i nervesystemetForenede Stater